Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database.

For instance, CTLA-4 inhibitors were associated with a higher incidence of colitis and diarrhea, while PD-1 inhibitors showed a strong trend toward immune-related AEs, again, congruent with the current literature [ 29 , 30 ].

also in 5,725 other papers